EUVIMEDScopri EUVIMED
Open access · CC BY-NC-ND 4.0

Retrospective evaluation of 22 dogs with leptospirosis treated with extracorporeal renal replacement therapies (2018-2021)

Antonia Da Fonseca Ioannou iD, Carolyn Tai, Mary Anna Labato iD, Emmanuelle M Butty iD

Journal of Veterinary Internal Medicine · 2024-03-01 · 38 (2) · 1051-1059

DOI: 10.1111/jvim.16998 ↗

At a glance

Journal article in Journal of Veterinary Internal Medicine, published online on 2024-03-01. Written by Antonia Da Fonseca Ioannou and 3 co-authors. Institution: Department of Clinical Sciences, Tufts University, Cummings School of Veterinary Medicine, Foster Hospital for Small Animals, North Grafton, Massachu…. Major MEDLINE topics: Acute Kidney Injury, Dog Diseases. Cited 5 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Outcomes of dogs with acute kidney injury secondary to leptospirosis (AKI-L) treated using renal replacement therapies (RRT) are poorly characterized. Hypothesis/Objectives Describe survival to discharge, short (≤30 days) and long-term (≥6 months) outcomes of AKI-L dogs receiving RRT and determine if there is a significant difference in maximum blood urea nitrogen (maxBUN), maximum creatinine (maxCr), maximum bilirubin (maxBili) and the number of body systems affected between survivors and non-survivors. Animals Twenty-two client-owned dogs with AKI-L receiving RRT.

Methods

Retrospective medical record review of dogs with AKI-L that received RRT between 2018 and 2021.

Results

Sixteen of 22 (73%) dogs survived to discharge. Of the survivors, 13 (81%) were alive >30 days from discharge and 12 (75%) were alive at 6 months from discharge. Factors significantly higher in non-survivors included number of body systems affected (survivors: 1 (19%), 2 (50%), 3 (25%) and 4 (6%) vs non-survivors: 3 (33.3%), and 4 (66.7%); P = .01) and median maxBili (survivors: 1.9 mg/dL; range, 0.1-41.6 vs non-survivors: 21.0 mg/dL; range, 12.3-38.9; P = .02). There was no significant difference in median maxBUN (survivors: 153.0 mg/dL; range, 67-257 vs non-survivors: 185.5 mg/dL; range, 102-218; P = .44) and median maxCr (survivors: 9.8 mg/dL; range, 6.2-15.9 vs non-survivors: 9.8 mg/dL; range, 8.4-13.5; P = .69) between survivors and non-survivors. Conclusions and Clinical Importance Regardless of azotemia severity, dogs with AKI-L receiving RRT have a good survival rate to discharge. The number of body systems affected and hyperbilirubinemia might be associated with worse outcomes.

Subjects

MeSH terms (MEDLINE)

Acute Kidney InjuryDog DiseasesHumansDogsAnimalsRetrospective StudiesRenal Replacement TherapyBlood Urea Nitrogen

Author keywords

Leptospiraacute kidney injuryanuriaazotemiacaninecontinuous renal replacement therapyhemoperfusionintermittent hemodialysisoliguria

Authors and institutions

  • Department of Clinical Sciences, Tufts University, Cummings School of Veterinary Medicine, Foster Hospital for Small Animals, North Grafton, Massachusetts, USA.

ORCID profiles: Antonia Da Fonseca Ioannou, Mary Anna Labato, Emmanuelle M Butty

Cite

APA

Ioannou, A. D. F., Tai, C., Labato, M. A., & Butty, E. M. (2024). Retrospective evaluation of 22 dogs with leptospirosis treated with extracorporeal renal replacement therapies (2018-2021). Journal of Veterinary Internal Medicine, 38(2), 1051-1059. https://doi.org/10.1111/jvim.16998

Vancouver

Ioannou ADF, Tai C, Labato MA, Butty EM. Retrospective evaluation of 22 dogs with leptospirosis treated with extracorporeal renal replacement therapies (2018-2021). Journal of Veterinary Internal Medicine. 2024;38(2):1051-1059. doi:10.1111/jvim.16998

BibTeX
@article{Ioannou2024,
  author = {Ioannou, Antonia Da Fonseca and Tai, Carolyn and Labato, Mary Anna and Butty, Emmanuelle M},
  title = {Retrospective evaluation of 22 dogs with leptospirosis treated with extracorporeal renal replacement therapies (2018-2021)},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2024},
  volume = {38},
  number = {2},
  pages = {1051--1059},
  doi = {10.1111/jvim.16998}
}
Start for free →